After treating bladder cancer cells with a UBE2V1/UBC13 inhibitor, both ubiquitination and expression of Lin28a were affected, and UBC13 was found to interact with Lin28a, indicating that UBE2V1/UBC13 regulates the ubiquitination of Lin28a. Here, UBE2V1 is linked to urinary bladder cancer.